Head-to-head
MEDVi vs Luvo Health
Compared on both medications across the eight dimensions this database records. They differ on 6 of those eight. Luvo Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
MEDVi is $399 a month all-in for tirzepatide; Luvo Health is $339. Over twelve months that is $4,788 against $3,492. Value Scores are 57.4 and 50.4 out of 100.
Tirzepatide
Plan pages: MEDVi plans · Luvo Health plans
At 10 mg/week, MEDVi is $399 a month all-in and Luvo Health is $339 — $60 apart, or $720 across a year. Over twelve months the totals are $4,788 (billed monthly) and $3,492 (prepaid term).
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Luvo Health charges a flat $339 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | MEDVi | Rank | Luvo Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $399 | 27/31 | $339 | 22/31 | Luvo Health by $60 |
| 5 mg | $399 | 15/17 | — | — | only MEDVi publishes |
| 7.5 mg | $399 | 14/17 | — | — | only MEDVi publishes |
| 10 mg | $399 | 21/27 | $339 | 16/27 | Luvo Health by $60 |
| 12.5 mg | $399 | 14/17 | — | — | only MEDVi publishes |
| 15 mg | $399 | 14/17 | — | — | only MEDVi publishes |
Luvo Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, MEDVi sits 21 of 27 on all-in monthly cost and Luvo Health sits 14. There are 6 other programs priced between them. The field median is $339 and the floor is $169, so Luvo Health is below the median and the other is above it. MEDVi is $230 above the cheapest tirzepatide program on record. Luvo Health is $170 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — MEDVi undercuts it by $50, Luvo Health by $110. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | MEDVi | Luvo Health | Cheaper |
|---|---|---|---|
| Month to month | $399 | $339 | Luvo Health by $60 |
| 12-month term | — | $291 | only Luvo Health publishes this term |
| Settled dose | MEDVi | Luvo Health | Difference |
|---|---|---|---|
| 2.5 mg | $4,788 | $4,068 | $720 apart |
| 5 mg | $4,788 | — | one side unpriced |
| 7.5 mg | $4,788 | — | one side unpriced |
| 10 mg | $4,788 | $4,068 | $720 apart |
| 12.5 mg | $4,788 | — | one side unpriced |
| 15 mg | $4,788 | — | one side unpriced |
MEDVi publishes no rate for 3-month term, 6-month term, 12-month term; Luvo Health publishes none for 3-month term, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,788 on MEDVi and $4,068 on Luvo Health. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Luvo Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 57.4 for MEDVi and 50.4 for Luvo Health, against a tirzepatide category floor of $169. MEDVi leads by 7.0 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| MEDVi | 29.6 | 12.8 | 10 | 5 | 57.4 |
| Luvo Health | 34.9 | 10.5 | 0 | 5 | 50.4 |
Semaglutide
Plan pages: MEDVi plans · Luvo Health plans
At 2.4 mg/week, MEDVi is $299 a month all-in and Luvo Health is $249 — $50 apart, or $600 across a year. Over twelve months the totals are $3,588 (billed monthly) and $2,328 (prepaid term).
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Luvo Health charges a flat $249 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Luvo Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 58.0 for MEDVi and 51.8 for Luvo Health, against a semaglutide category floor of $129. MEDVi leads by 6.2 points, driven mostly by price.
Where the two programs differ
All-in monthly
Luvo Health is cheaper month to month — $339 against $399, a gap of $60 every month, or $720 across a year if both rates hold.
Cancellation terms
Cancellation differs: MEDVi states Cancel before renewal, while Luvo Health states No-commitment 4-week option available; confirm annual plan refund terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
MEDVi asks for Month-to-month; Luvo Health asks for 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
MEDVi charges one price at every dose; Luvo Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. MEDVi's figure is provider-stated and Luvo Health's is reported. MEDVi rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $4,788 for MEDVi and $3,492 for Luvo Health. Luvo Health is lower by $1,296 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Luvo Health Official site
Luvo Health publishes an openly available price ladder for compounded GLP-1s — semaglutide and tirzepatide — alongside longevity peptides. It names four dispensing pharmacy partners. Its 52-week (annual) plan offers the lowest per-month-equivalent rate; no-commitment 4-week terms cost materially more.
It does not publicly name its compounding pharmacy; the record shows Four named dispensing compounding pharmacies (specific names per provider materials), so who actually makes the medication cannot be independently verified; commitment terms are 52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment); cancellation is No-commitment 4-week option available; confirm annual plan refund terms; availability is stated as All 50 states claimed; some services may not be available in all states per Luvo terms.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Luvo published $3,497 term total, verified 2026-08-08
Watch: Luvo publishes plan-TERM totals in weeks, not monthly prices; our monthly figures divide the term total by 12 calendar months, but 52 weeks = 13 four-week cycles, so the true per-cycle cost is slightly different. Luvo makes no third-party testing claim and its own evaluation does not include lab testing. Geographic availability is a qualified all-50-states claim. Reported status — RangeYourself verified 2026-08-08.
What neither record tells you
MEDVi does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Luvo Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no named compounding pharmacy
Ask MEDVi and Luvo Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Luvo Health carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. Luvo Health publishes a twelve-month rate of $291 a month against $339 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Luvo Health Official site wins this matchup. If you expect to titrate to the top of the ladder, medvi's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, medvi's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. MEDVi's tirzepatide price is provider-stated as of 2026-08-05; Luvo Health's is reported as of 2026-08-08.
Questions
Is MEDVi or Luvo Health cheaper for tirzepatide?
Luvo Health is cheaper on all-in monthly cost at 10 mg/week: $339 against $399, a difference of $60 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of MEDVi versus Luvo Health?
MEDVi works out to $4,788 across twelve months and Luvo Health to $3,492, on the plan terms each publishes.
Does MEDVi or Luvo Health raise the price as the dose goes up?
MEDVi: no, it charges one flat rate at every dose. Luvo Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do MEDVi and Luvo Health differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of MEDVi and Luvo Health names its pharmacy?
Neither. MEDVi records Partner pharmacies and Luvo Health records Four named dispensing compounding pharmacies (specific names per provider materials). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the MEDVi and Luvo Health prices?
MEDVi's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Luvo Health's is reported, captured 2026-08-08. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Luvo Health, at $249 a month all-in against $299 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: MEDVi official site · Luvo Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.